Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain-containing protein 13D (ANKRD13D) is a member of the ankyrin repeat domain (ANKRD) 13 family that contains ubiquitin-interacting motifs[2][12]. This integral membrane-associated protein specifically recognizes and binds Lys-63-linked ubiquitin chains, distinguishing them from Lys-48 chains, and regulates the internalization of ligand-activated receptors such as EGFR by binding to their ubiquitinated forms at the cell membrane[2][3][13]. ANKRD13D’s function is implicated in receptor endocytosis and trafficking, acting as a molecular scaffold and negative regulator of receptor internalization[1][5][6][11]. ANKRD13D is reported as a potential tumor-specific target in renal cell carcinoma and may act as an immune regulator, opening avenues for immunotherapeutic approaches in oncology[4]. There are no known drugs approved to target ANKRD13D, no established mechanisms of drug action, nor established biomarker or safety concern profiles[2][4][12].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain-containing protein 13D (ANKRD13D).